Biobide’s team presents zebrafish as alternative model for cancer research in BIO2018

BIO International Convention is the largest global event for biotechnology industry organized by Biotechnology Innovation Organization, representing biotechnology companies, academic institutions, biotechnology centers and related organizations in the United States and in more than 30 other countries. More than 18,000 attendees gathered to this year’s conference in Boston, MA, USA, where cutting-edge innovations in the industry were presented by leading companies and clusters from 67 countries.

Biobide’s team members have been participating and presenting our zebrafish service pipeline in the BIO International Convention since 2008 and this year was not an exception. Biobide USA’s CEO Arantza Muriana and Biobide’s Managing Director Andoni Cruz presented a poster “Zebrafish as Alternative Model for Cancer Research” in the BIO’s 7th International Cancer Cluster Showcase. They introduced the audience to zebrafish model application in target validation, cancer models’ generation, angiogenesis inhibition and immuno-oncology.

For further information please contact us .

To find out more about the event, visit official BIO International Convention and International Cancer Cluster Showcase websites.

Arantza Muriana, Andoni Cruz, BIO International Convention, International Cancer Cluster, oncology, zebrafish, cancer
About the Author